GyneFix IUD: How the Frameless Copper Device Works

The GyneFix is a frameless copper intrauterine device that works differently from the T-shaped or horseshoe-shaped IUDs most people picture. Instead of a rigid plastic frame, it consists of small copper sleeves threaded onto a length of surgical suture, with the upper end anchored directly into the muscle wall at the top of the uterus. That design choice has real consequences for who can use it comfortably, how it behaves once placed, and why it remains unavailable in several major markets despite decades of clinical data.

What Makes the Design Different

Conventional copper IUDs like the TCu380A have a T-shaped plastic frame that holds the device open inside the uterine cavity. The arms of the T press against the cavity walls, which is how the device stays in place. That works well in many uteruses, but it also means the device has a fixed width that may not match every cavity shape or size. If the fit is poor, the uterus can push against the frame, leading to cramping, abnormal bleeding, or outright expulsion.

The GyneFix eliminates the frame entirely. Its copper sleeves hang freely on a thread, so the device has essentially no horizontal dimension and moves with the uterus rather than against it. Because there is nothing rigid to push against the cavity walls, the uterus cannot generate the expulsive forces that eject conventional IUDs.¹ The trade-off is that without a frame to hold it in position by pressure alone, the device needs another way to stay put.

That other way is an anchor. A tiny preformed surgical knot at the top of the suture thread is pushed into the myometrium, the muscular layer of the uterine fundus. The tissue grows around the knot and holds the device in place.² This anchoring step is what distinguishes GyneFix insertion from every other IUD on the market and is the reason provider training matters more than usual.

How Well It Prevents Pregnancy

The contraceptive performance of GyneFix has been tested head-to-head against the TCu380A, which is one of the most effective copper IUDs available worldwide and often serves as the benchmark. In an eight-year multicenter randomized trial, first-year pregnancy rates were about 1.3 per 100 users for the frameless device and 0.5 per 100 for the TCu380A. That gap narrowed and then reversed over time: cumulative pregnancy rates from year two through year eight were roughly 1.2 per 100 for GyneFix and 2.5 per 100 for the TCu380A.³ In practical terms, that means the two devices are comparably effective over several years, with GyneFix performing slightly better the longer it stays in place.

A separate three-year trial in parous women reported no pregnancies at all with GyneFix over the study period, compared with a cumulative pregnancy rate of 0.34 per 100 for the TCu380A.⁴ A study of the GyneFix 200, a version with a smaller copper surface area designed for smaller uteruses, found a cumulative failure rate of about 0.5 per 100 at three years, with no cases of pelvic inflammatory disease or perforation in that particular cohort.⁵

The eight-year trial also found that removals for pain were lower with the frameless device than with the TCu380A, and ectopic pregnancy rates were lower as well.⁶ Those secondary outcomes matter because an IUD that gets removed early due to side effects is no longer preventing pregnancy, regardless of how effective it was while in place.

Expulsion Rates and the Introducer Problem

Early clinical experience with GyneFix had a genuine expulsion problem. A Cochrane review of trials comparing frameless and framed IUDs found that the two earlier trials, which used a prototype insertion instrument, showed a higher expulsion rate at one year for the frameless device. But the story changed with a redesigned introducer. In a later trial using the updated tool, early expulsions were not statistically different from the framed IUD, and by year three the expulsion rate with GyneFix was actually lower.⁷

The three-year trial in parous women put numbers on this more clearly. GyneFix had a cumulative expulsion rate of about 3 per 100 at three years, compared with roughly 7.4 per 100 for the TCu380A. The total rate of use-related discontinuation at three years was also significantly lower with GyneFix, which translated into a higher continuation rate: about 91 per 100 versus 85 per 100 for the framed device.⁸ With the GyneFix 200, the three-year expulsion rate was even lower, at about 0.4 per 100.⁹

The takeaway is that the insertion tool matters a lot. Early data looked concerning for expulsions, but the problem turned out to be the instrument rather than the concept. With the current introducer and proper technique, expulsion rates compare favorably to conventional IUDs.

What Insertion Feels Like

Because the device must be anchored into the muscular wall of the uterus, the insertion procedure is different from placing a standard IUD. A randomized trial comparing GyneFix to the Gyne-T380S found that the actual insertion was scored as more painful for GyneFix, both by the women receiving it and by the clinicians observing their pain responses. However, the same trial found that women with GyneFix reported less pain during the thirty days after insertion. And fewer GyneFix users requested removal: about 13 percent asked to have it taken out, versus 20 percent of those who received the framed device, with the difference largely driven by pain-related removals.¹⁰

A Spanish cohort study found that providers rated GyneFix insertion as easy in about 92 percent of cases, though nulliparous women, those who have never given birth, experienced more symptoms during the procedure and the insertion was more technically challenging in that group.¹¹ The pattern that emerges is a sharper initial sting during placement but a more comfortable experience afterward, which makes intuitive sense: the anchoring step is an extra moment of discomfort, but the resulting device is smaller and more flexible than a framed IUD pressing on cavity walls.

Why It Suits Smaller Uteruses

One of the strongest arguments for a frameless IUD shows up when you look at uterine cavity measurements. A multicenter study using ultrasound in over 400 nulliparous women found that uterine cavities in this group are usually narrow and rarely wide enough to comfortably accommodate conventional T-shaped IUDs. When there is a large mismatch between the device and the cavity, the result tends to be embedment, pain, bleeding, or expulsion. The researchers suggested this dimensional mismatch may explain why five-year continuation rates with conventional IUDs in nulliparous women have historically been only around 40 to 50 percent. Because the frameless IUD has no fixed width, pre-procedure measurement of cavity width is unnecessary.¹²

A multicenter study of GyneFix in young nulliparous and adolescent women reinforced this point, finding that the device adapts to cavities of every size and shape precisely because it lacks a horizontal dimension.¹³ This compatibility with small cavities leads to higher acceptability and continuation, which is especially relevant in a population that contributes disproportionately to unintended pregnancies. Researchers have argued that frameless IUDs should be considered as first-line options for interval, emergency, and immediate post-abortion contraception in adolescents and young nulliparous women.¹⁴

Menstrual Bleeding Changes

One common concern with copper IUDs is heavier or more painful periods. With framed copper devices, some increase in menstrual blood loss is typical, at least in the first several months. The GyneFix 200 appears to sidestep much of this problem. A study tracking menstrual blood loss in Belgian users of the GyneFix 200 over an average observation period of about 31 months found that blood loss scores did not change from baseline.¹⁵ That is a meaningful finding, because increased bleeding is one of the top reasons women have copper IUDs removed. A device that does not change your period is a device you are more likely to keep.

The likely explanation is a combination of the smaller copper surface area in the GyneFix 200 (200 square millimeters versus 380 in a standard TCu380A) and the absence of a rigid frame pressing into the endometrium. Both factors could reduce the local irritation that drives heavier bleeding with conventional copper IUDs. The standard GyneFix with more copper surface area may produce slightly more menstrual change, but even the eight-year trial showed fewer pain-related removals with GyneFix than with the TCu380A.¹⁶

Perforation Risk and Why Training Matters

The anchoring step that gives GyneFix its advantage also introduces a risk that standard IUDs do not have in quite the same way. Because the inserter pushes a knot into the myometrium, there is a possibility of pushing too deep and perforating the uterine wall. Case reports have documented perforations occurring as early as eleven days and as late as four months after insertion.¹⁷ A separate case report described a perforation two months post-insertion, noting that the true incidence of this complication is unknown and may be underreported.¹⁸

The risk is not unique to GyneFix. Perforation can happen with any IUD. But the mechanism differs: with a framed IUD, perforation typically occurs when the device migrates through the wall over time, whereas with GyneFix the concern is about the depth of the initial anchoring. This makes provider technique and pre-insertion assessment critical. Guidance for GyneFix insertions recommends assessing the thickness of the uterine fundal wall beforehand and specifies that the fundal muscle should be at least 10 millimeters thick in the midline. Ultrasound assessment before placement helps ensure a safe insertion.¹⁹

The practical implication is that GyneFix insertion requires specific training that goes beyond what is needed for placing a standard IUD. A provider who is experienced with T-shaped devices is not automatically qualified to insert a frameless one. Finding a trained provider can be a barrier, particularly in countries where the device is not widely marketed.

Fertility After Removal

A common question with any long-acting contraceptive is how quickly fertility returns once the device is taken out. For GyneFix, the data is reassuring. A study tracking 128 past users found that 93 percent conceived after removal, with a cumulative pregnancy rate of about 88 percent at twelve months and 99 percent after two years. There were no ectopic pregnancies in the cohort, and the duration of prior GyneFix use did not affect how quickly women became pregnant. The only significant difference in conception rates was between women who had previously given birth and those who had not, which reflects general fertility patterns rather than any device-specific effect.²⁰

Removal itself is straightforward, though the anchored design means it is not identical to pulling out a standard IUD. The thread is grasped and pulled downward, and the knot releases from the myometrium. A study comparing removal force in premenopausal and postmenopausal women found that the force needed was higher with a thicker anchoring thread, and postmenopausal tissue required somewhat more force, but neither finding had clinical significance in practice.²¹

Where You Can Actually Get One

GyneFix has CE marking in Europe and is available in several European and Asian countries. It is not approved by the FDA and is not available in the United States, Canada, or Australia. For people in countries where it is sold, the main access challenge is finding a provider who has completed the specific insertion training. The device has been manufactured and promoted primarily by Contrel Research in Belgium, and its availability has always been somewhat niche compared with the large-scale distribution networks behind devices like Mirena or Paragard.

The limited geographic availability is partly regulatory and partly commercial. Bringing a device to market in the U.S. requires separate FDA approval, which involves substantial cost and clinical trial infrastructure. For a relatively small manufacturer, the investment may not be justified when the American IUD market is already dominated by established products. In the UK, GyneFix was previously available but its status has fluctuated depending on distribution agreements, and accessing it has sometimes required seeking out specific sexual health clinics that stock it.

For people who want a copper IUD but have had trouble with framed devices due to a small uterus, heavy cramping, or repeated expulsions, GyneFix represents a genuinely different approach rather than just a minor redesign. The evidence supporting it is solid if not massive in volume. The development of frameless intrauterine technology has been described as an attempt to solve the main problems encountered with conventional IUDs, including expulsion, abnormal bleeding, and pain.²² Whether it fulfills that promise depends largely on whether you can find a trained provider and whether your country’s regulatory system has given it the green light.

Cesarean Delivery Insertion

A more recent area of research involves placing GyneFix during cesarean sections. The idea is that when the uterus is already open during surgery, the device can be inserted and the anchor knot secured directly under visual guidance, with an additional biodegradable suture through the uterine serosa for extra security. This dual-anchoring approach was designed specifically to prevent the high expulsion rates that have plagued IUD insertion during cesarean delivery with conventional devices.²³ Immediate postpartum IUD placement is attractive because it catches women at a moment when they are already in a clinical setting and motivated to begin contraception, but expulsion rates with framed IUDs placed at this time are substantially higher than with interval placement. The frameless design with surgical fixation is an attempt to close that gap.

This application remains in relatively early clinical evaluation. The observational data is promising but limited, and it would take larger trials with longer follow-up before cesarean-section insertion of GyneFix could be considered standard practice. Still, it illustrates how the anchoring concept opens up clinical scenarios that are awkward or unreliable with conventional IUD designs.